Abiopharma

NASDAQ symbol attribute type Security_Name was changed. Previous value: Immatics N.V. - Warrants. New value: Immatics N.V. - Warrants.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Immatics N.V. - Warrants.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Synaptogenix, Inc. - Common Stock. New value: Synaptogenix, Inc. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Synaptogenix, Inc. - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Immatics N.V. - Warrants.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Synaptogenix, Inc. - Common Stock.

Indivior Notification

General Announcement: ISSUANCE OF SHARES PURSUANT TO EXERCISE OF WARRANTS

Employee Stock Option/ Share Scheme: ISSUANCE OF SHARES PURSUANT TO ENTERPRISE OPTION SCHEME

Cybin - Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights

Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

New Form SCHEDULE 13D/A - Ontrak, Inc. Filed: 2025-06-30 AccNo: 0001104659-25-064325 Size: 167 KB

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock